Shareholders' equity · 2013–2025
Syndax Pharmaceuticals shareholders' equity
$64.6M−77.6% · FY2025
Syndax Pharmaceuticals (SNDX) reported $64.6M in shareholders' equity for fiscal 2025, −77.6% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $64.6M | −77.6% | Open → |
| FY20242024-12-31 | $288M | −48.0% | Open → |
| FY20232023-12-31 | $554M | +18.6% | Open → |
| FY20222022-12-31 | $467M | +14.5% | Open → |
| FY20212021-12-31 | $408M | +61.9% | Open → |
| FY20202020-12-31 | $252M | +698.1% | Open → |
| FY20192019-12-31 | $31.6M | −40.4% | Open → |
| FY20182018-12-31 | $53.0M | −49.1% | Open → |
| FY20172017-12-31 | $104M | +24.0% | Open → |
| FY20162016-12-31 | $84.1M | +$337M | Open → |
| FY20152015-12-31 | −$252M | −$99.8M | Open → |
| FY20142014-12-31 | −$153M | −$24.1M | Open → |
| FY20132013-12-31 | −$128M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Syndax Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/syndax-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Syndax Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/syndax-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-syndax-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Syndax Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/syndax-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-332750 · August 4, 2026
{{cite web |title=Syndax Pharmaceuticals shareholders' equity — 10-Q (0001193125-26-332750) |url=https://www.sec.gov/Archives/edgar/data/1395937/000119312526332750/sndx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.